Japan Urges Public To Get Single-Shot Protection Against Flu Types
This article was originally published in PharmAsia News
Executive SummaryJapanese medical experts are urging the general public once again to get influenza shots, and point out that a single shot should protect against several flu types
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.